AZoNano.com reporter, Cameron Chai caught up with Jackie Fairley, CEO of Starpharma
to ask her where Starpharma is heading with it’s leading nanotech products
for pharmaceutical, life sciences and related applications.
In this insightful interview, Jackie Fairley discusses how the innovative nanoparticulate
based dendrimer technology developed by Starpharma can be modified or customized
to cater for specific applications.
Jackie also sheds light on the history of this innovative Australian-based
company and how they have welcomed foreign investment to aid in their global
growth. Growth to be driven by their Vivagel technology, licensed to SSL in
the UK, a market leader in condom manufacture. For Starpharma, entry into this
market has the potential to yield revenues in excess of AUD$100 million.
A Nanotech company to watch!
To hear this interview in full, please click here.